Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report

Nivolumab in combination with radiotherapy for metastatic esophageal neuroendocrine carcinoma after esophagectomy: a case report

Abstract Background Metastatic neuroendocrine carcinoma has an extremely poor prognosis, and no effective second-line treatment is available. Herein, we describe a case of multiple metastases after primary resection of esophageal neuroendocrine carcinoma successfully treated with nivolumab plus radi...

Full description

Bibliographic Details
Main Authors: Kuniyasu Takagi, Teppei Kamada, Yoshinobu Fuse, Wataru Kai, Junji Takahashi, Keigo Nakashima, Yuichi Nakaseko, Norihiko Suzuki, Masashi Yoshida, Shinya Okada, Hironori Ohdaira, Yutaka Suzuki
Format: Article
Language:English
Published: SpringerOpen 2021-10-01
Series:Surgical Case Reports
Subjects:
Immune checkpoint inhibitors
Neuroendocrine carcinoma
Radiotherapy
Online Access:https://doi.org/10.1186/s40792-021-01307-3

Internet

https://doi.org/10.1186/s40792-021-01307-3

Similar Items